Patients Deserve Better

New medicines can’t help if patients can’t access them

Irish people with multiple sclerosis (MS) are waiting for medicines that people in other European countries already have access to.  This is because the Irish system for making medicines publicly available is broken.

A recent analysis found that patients in Germany and Denmark for example were able to access life-changing medicines within an average of 119 and 146 days respectively1 from the date of European Medicines Agency (EMA) licensing. Yet patients in Ireland waited an average of 486 days1 to get access to the same medicines.

Patients deserve better.

People with MS can’t wait.

Irish people with MS need, expect and deserve quick access to new, innovative and effective treatments through a public system that is fair and sustainable.